Skip to main content

Table 3 Recovery and precision of EMPA and its related substances

From: A UPLC/DAD method for simultaneous determination of empagliflozin and three related substances in spiked human plasma

Compound

Concentration added (ng/mL)

Intra-day%

(n = 5)

Inter-day%

(n = 5)

Concentration found (ng/mL)

Recovery % (n = 5)

%RSD

Concentration found (ng/mL)

Recovery % (n = 5)

%RSD

EMPA

50 (LLOQ)

46.21

92.42

13.8

47.15

94.30

11.1

100 (LQC)

98.60

98.60

4.34

96.22

96.22

6.38

300 (MQC)

293.79

97.93

5.90

301.7

100.6

9.45

500 (HQC)

501.36

100.27

4.22

494.3

98.86

3.61

700 (ULOQ)

673.54

96.22

3.67

706.5

100.9

2.59

Mean

  

97.09

6.38

 

98.18

6.63

ERS1

40 (LLOQ)

36.19

90.48

11.9

43.71

109.3

12.4

80 (LQC)

84.48

105.6

6.76

75.98

94.98

9.11

120 (MQC)

114.6

95.50

8.42

110.7

92.25

8.92

160 (HQC)

154.9

96.84

3.90

156.2

97.63

4.15

200 (ULOQ)

201.7

100.9

5.32

206.3

103.2

5.07

Mean

  

97.86

7.26

 

99.47

7.93

ERS2

40 (LLOQ)

36.68

91.70

13.2

35.82

89.55

14.3

80 (LQC)

77.86

97.33

5.92

75.37

94.21

7.05

120 (MQC)

125.5

104.6

7.09

118.6

98.83

2.64

160 (HQC)

164.6

102.9

6.39

169.4

105.9

6.08

200 (ULOQ)

199.7

99.85

7.11

204.9

102.5

2.94

Mean

  

99.28

7.94

 

98.20

6.60

ERS3

40 (LLOQ)

37.72

94.30

14.6

38.70

96.75

12.9

80 (LQC)

81.68

102.1

9.63

79.11

98.89

10.3

120 (MQC)

111.7

93.08

6.37

122.9

102.4

7.25

160 (HQC)

154.9

97.34

4.08

164.3

102.7

3.69

200 (ULOQ)

196.1

98.05

2.01

195.2

97.60

2.98

Mean

  

96.97

7.34

 

99.67

7.42